• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化症中正常外观灰质的神经元和轴突损失以及软脑膜下病变。

Neuronal and axonal loss in normal-appearing gray matter and subpial lesions in multiple sclerosis.

作者信息

Klaver Roel, Popescu Veronica, Voorn Pieter, Galis-de Graaf Yvonne, van der Valk Paul, de Vries Helga E, Schenk Geert J, Geurts Jeroen J G

机构信息

From the Departments of Anatomy and Neurosciences (RK, PV, YGdG, GJS, JJGG), Radiology and Nuclear Medicine (VP), Pathology (PvdV), and Molecular Cell Biology and Immunology (HEdV), VU University Medical Center, Neuroscience Campus, Amsterdam, the Netherlands.

出版信息

J Neuropathol Exp Neurol. 2015 May;74(5):453-8. doi: 10.1097/NEN.0000000000000189.

DOI:10.1097/NEN.0000000000000189
PMID:25853695
Abstract

Multiple sclerosis (MS) is a demyelinating and neurodegenerative disease of the CNS. Multiple sclerosis lesions include significant demyelination of the gray matter, which is thought to be a major contributor to both physical and cognitive impairment. Subpial (Type III) lesions are the most common demyelinated cortical lesions. We investigated neurodegenerative features of subpial lesions in cerebral cortex samples from 11 patients with MS and 6 nondemented non-MS controls. There were no significant differences in neuron and axon density between normally myelinated normal-appearing gray matter (NAGM) and Type III MS lesions. Neurons were 11.2% smaller in Type III lesions than in NAGM in the cingulate cortex only; Type III lesions contained 25.4% fewer NeuN-positive neurons compared with control cortex. Neurons in MS NAGM were 13.6% smaller than those in control cortex. Finally, the same regions, immunostained with anti-SMI312 antibodies, showed reduced axon densities in Type III lesions (-31.4%) and NAGM (-33.0%) compared with controls. In conclusion, both NAGM and Type III lesions showed neurodegenerative changes, but they had no consistent differences in neuronal and axonal alterations. This suggests that neurodegeneration in the cerebral cortex of patients with MS may be independent of cortical demyelination.

摘要

多发性硬化症(MS)是一种中枢神经系统的脱髓鞘和神经退行性疾病。多发性硬化症病变包括灰质的显著脱髓鞘,这被认为是导致身体和认知障碍的主要因素。软脑膜下(III型)病变是最常见的脱髓鞘皮质病变。我们研究了11例多发性硬化症患者和6例无痴呆的非多发性硬化症对照者大脑皮质样本中软脑膜下病变的神经退行性特征。正常髓鞘化的正常外观灰质(NAGM)和III型多发性硬化症病变之间的神经元和轴突密度没有显著差异。仅在扣带回皮质中,III型病变中的神经元比NAGM中的神经元小11.2%;与对照皮质相比,III型病变中NeuN阳性神经元减少25.4%。多发性硬化症NAGM中的神经元比对照皮质中的神经元小13.6%。最后,用抗SMI312抗体免疫染色的相同区域显示,与对照相比,III型病变(-31.4%)和NAGM(-33.0%)中的轴突密度降低。总之,NAGM和III型病变均显示神经退行性变化,但它们在神经元和轴突改变方面没有一致的差异。这表明多发性硬化症患者大脑皮质中的神经退行性变可能与皮质脱髓鞘无关。

相似文献

1
Neuronal and axonal loss in normal-appearing gray matter and subpial lesions in multiple sclerosis.多发性硬化症中正常外观灰质的神经元和轴突损失以及软脑膜下病变。
J Neuropathol Exp Neurol. 2015 May;74(5):453-8. doi: 10.1097/NEN.0000000000000189.
2
Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter.多发性硬化症深部灰质中的脱髓鞘、炎症和神经退行性变。
J Neuropathol Exp Neurol. 2009 May;68(5):489-502. doi: 10.1097/NEN.0b013e3181a19a5a.
3
Ultra-high field MTR and qR2* differentiates subpial cortical lesions from normal-appearing gray matter in multiple sclerosis.超高场 MTR 和 qR2* 可区分多发性硬化症中的软脑膜皮质病变与正常外观的灰质。
Mult Scler. 2016 Sep;22(10):1306-14. doi: 10.1177/1352458515620499. Epub 2015 Dec 16.
4
High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis.多发性硬化症皮质灰质病变的高磁场(9.4 特斯拉)磁共振成像。
Brain. 2010 Mar;133(Pt 3):858-67. doi: 10.1093/brain/awp335. Epub 2010 Jan 31.
5
Oligodendrocyte gap junction loss and disconnection from reactive astrocytes in multiple sclerosis gray matter.多发性硬化症灰质中少突胶质细胞间隙连接丧失及与反应性星形胶质细胞的脱联
J Neuropathol Exp Neurol. 2014 Sep;73(9):865-79. doi: 10.1097/NEN.0000000000000106.
6
Subpial demyelination in the cerebral cortex of multiple sclerosis patients.多发性硬化症患者大脑皮质的软膜下脱髓鞘病变
J Neuropathol Exp Neurol. 2003 Jul;62(7):723-32. doi: 10.1093/jnen/62.7.723.
7
Metabolic gene expression changes in astrocytes in Multiple Sclerosis cerebral cortex are indicative of immune-mediated signaling.多发性硬化症大脑皮层星形胶质细胞代谢基因表达变化提示免疫介导的信号转导。
Brain Behav Immun. 2015 Aug;48:313-25. doi: 10.1016/j.bbi.2015.04.013. Epub 2015 Apr 30.
8
Accumulation of cortical hyperphosphorylated neurofilaments as a marker of neurodegeneration in multiple sclerosis.皮质过度磷酸化神经丝的积累作为多发性硬化症神经退行性变的标志物。
Mult Scler. 2013 Feb;19(2):153-61. doi: 10.1177/1352458512451661. Epub 2012 Jun 21.
9
Cortical neuronal densities and cerebral white matter demyelination in multiple sclerosis: a retrospective study.多发性硬化症中的皮质神经元密度和脑白质脱髓鞘:一项回顾性研究。
Lancet Neurol. 2018 Oct;17(10):870-884. doi: 10.1016/S1474-4422(18)30245-X. Epub 2018 Aug 22.
10
Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions.皮质多发性硬化病变中的神经突横断、凋亡神经元及炎症减轻。
Ann Neurol. 2001 Sep;50(3):389-400. doi: 10.1002/ana.1123.

引用本文的文献

1
Brain Atrophy and Cognitive Impairment in Primary and Secondary Progressive Multiple Sclerosis Cohort-Similar Progressive MS Phenotype.原发进展型和继发进展型多发性硬化队列中的脑萎缩与认知障碍——相似的进展型多发性硬化表型
Int J Mol Sci. 2025 Sep 2;26(17):8523. doi: 10.3390/ijms26178523.
2
A focus on the normal-appearing white and gray matter within the multiple sclerosis brain: a link to smoldering progression.聚焦多发性硬化症患者大脑中外观正常的白质和灰质:与隐匿性进展的关联
Acta Neuropathol. 2025 Aug 10;150(1):16. doi: 10.1007/s00401-025-02923-1.
3
Inflammatory mechanisms underlying cortical injury in progressive multiple sclerosis.
进展性多发性硬化症中皮质损伤的炎症机制
Neuroimmunol Neuroinflamm. 2021;8:111-133. doi: 10.20517/2347-8659.2020.35. Epub 2021 Jun 20.
4
Calpain inhibition as a possible new therapeutic target in multiple sclerosis.钙蛋白酶抑制作为多发性硬化症可能的新治疗靶点
AIMS Mol Sci. 2017;4(4):446-462. doi: 10.3934/molsci.2017.4.446. Epub 2017 Oct 26.
5
Towards a biological view of multiple sclerosis from early subtle to clinical progression: an expert opinion.从早期细微变化到临床进展,构建多发性硬化症的生物学视角:专家意见
J Neurol. 2025 Feb 1;272(2):179. doi: 10.1007/s00415-025-12917-4.
6
Cortical lesions impact cognitive decline in multiple sclerosis via volume loss of nonlesional cortex.皮质病变通过非病变皮质的体积减少影响多发性硬化症的认知衰退。
Ann Clin Transl Neurol. 2025 Jan;12(1):121-136. doi: 10.1002/acn3.52261. Epub 2024 Dec 27.
7
Should We Consider Neurodegeneration by Itself or in a Triangulation with Neuroinflammation and Demyelination? The Example of Multiple Sclerosis and Beyond.我们应该单独考虑神经退行性变,还是将其与神经炎症和脱髓鞘联系起来综合考量?以多发性硬化症及其他疾病为例。
Int J Mol Sci. 2024 Nov 25;25(23):12637. doi: 10.3390/ijms252312637.
8
C1ql1 expression in oligodendrocyte progenitor cells promotes oligodendrocyte differentiation.少突胶质前体细胞中C1ql1的表达促进少突胶质细胞分化。
FEBS J. 2025 Jan;292(1):52-74. doi: 10.1111/febs.17256. Epub 2024 Sep 11.
9
Cortical CD200-CD200R and CD47-SIRPα expression is associated with multiple sclerosis pathology.皮质CD200-CD200R和CD47-SIRPα表达与多发性硬化症病理学相关。
Brain Commun. 2024 Aug 7;6(4):fcae264. doi: 10.1093/braincomms/fcae264. eCollection 2024.
10
Time is myelin: early cortical myelin repair prevents atrophy and clinical progression in multiple sclerosis.时间就是髓鞘:早期皮质髓鞘修复可预防多发性硬化症的萎缩和临床进展。
Brain. 2024 Apr 4;147(4):1331-1343. doi: 10.1093/brain/awae024.